KG Co Gmbh Vi Partners Venture Sofinnova Net Worth & Insider Trades

KG Co Gmbh Vi Partners Venture Sofinnova Marinus Pharmaceuticals Inc

As of October 24, 2016

What is KG Co Gmbh Vi Partners Venture Sofinnova's Net Worth?

The current estimated net worth of Marinus Pharmaceuticals Inc's KG Co Gmbh Vi Partners Venture Sofinnova is estimated to be about $1.15M . KG Co Gmbh Vi Partners Venture Sofinnova owns about 15,470 units of Marinus Pharmaceuticals Inc common stock. In the last 2 years at Marinus Pharmaceuticals Inc, KG Co Gmbh Vi Partners Venture Sofinnova has sold an estimated value of $2.09M worth.

What is KG Co Gmbh Vi Partners Venture Sofinnova's Past Insider Trading?

KG Co Gmbh Vi Partners Venture Sofinnova's largest purchase order was 2,125,849 units , worth over $6.01M on August 7, 2014. KG Co Gmbh Vi Partners Venture Sofinnova's largest sale order was 750,683 units , worth over $1.04M on October 24, 2016. In total, KG Co Gmbh Vi Partners Venture Sofinnova has made about 4 transactions over 2 years of their time at Marinus Pharmaceuticals Inc. KG Co Gmbh Vi Partners Venture Sofinnova usually trades in October and August, with the busiest year in 2014 and 2016.

Anand Mehra, VI PARTNERS VENTURE SOFINNOVA, KG Co GmbH VI Partners Venture Sofinnova, Sofinnova Venture Affiliates VI LP, Sofinnova Management VI LLC, Eric Buatois, JAMES HEALY, Alain Azan, MICHAEL POWELL

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is KG Co Gmbh Vi Partners Venture Sofinnova's' Mailing Address?

  • Mailing address is 3000 Sand Hill Road, 4-250 Menlo Park CA 94025 CA

What are Marinus Pharmaceuticals Inc's Past Insider Trades?

Marinus Pharmaceuticals Inc's most recent insider trade came on February 8, 2023 by Seth Fischer who sold 1,018 units worth $6.66K . In the last 9 years, insiders at Marinus Pharmaceuticals Inc have sold an estimated value of $13.44M and bought an estimated value of $19.95M worth of shares. Insider trading is most common in January, with the busiest year in 2019, 2014 and 2017. The most active traders at the company are Nicole Vitullo, Director,  Edward F Smith, Former VP,  and Michael Christopher Cashman, CEO .

MARINUS PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...